Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.930
+0.270 (10.15%)
At close: Apr 20, 2026, 4:00 PM EDT
2.955
+0.025 (0.86%)
Pre-market: Apr 21, 2026, 5:04 AM EDT
Intelligent Bio Solutions Employees
As of June 30, 2025, Intelligent Bio Solutions had 55 total employees, including 53 full-time and 2 part-time employees. The number of employees increased by 5 or 10.00% compared to the previous year.
Employees
55
Change (1Y)
5
Growth (1Y)
10.00%
Revenue / Employee
$65,115
Profits / Employee
-$205,350
Market Cap
5.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 55 | 5 | 10.00% | 53 | 2 |
| Jun 30, 2024 | 50 | -1 | -1.96% | 50 | 0 |
| Jun 30, 2023 | 51 | 39 | 325.00% | 51 | 0 |
| Jun 30, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Jun 30, 2021 | 9 | 0 | - | 7 | 2 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Co-Diagnostics | 115 |
| Beyond Air | 61 |
| Biomerica | 54 |
| Tivic Health Systems | 52 |
| enVVeno Medical | 33 |
| Tenon Medical | 26 |
| HeartSciences | 15 |
| Autonomix Medical | 11 |
INBS News
- 20 hours ago - Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results - GlobeNewsWire
- 3 days ago - Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified - GlobeNewsWire
- 18 days ago - Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market - GlobeNewsWire
- 25 days ago - Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year - GlobeNewsWire